BSH 2018 | Genomic advancements in non-malignant hematology
Willem Ouwehand, MD, PhD, of the University of Cambridge, Cambridge, UK, discusses non-malignant hematology, particularly rare inherited disorders of hematopoietic stem cells and of the coagulation. He notes the culture of data sharing that has been predominant over the last few years, not just within the UK, but internationally, between consultant hematologists. Subsequently, this joint effort has facilitated molecular diagnoses for thousands of patients. Moreover, he applauds the efforts of the 100,000 Genomes Project, in so far as integrating genomics to the bedside. This video was recorded at the British Society for Haematology (BSH) 2018 Annual Scientific Meeting, held in Liverpool, UK.
Get great new content delivered to your inboxSign up